Mingming Xiao

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Top Venues

Science advances

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

He Xu, Di Wu, Mingming Xiao, Yubin Lei, Yalan Lei, Xian-Jun Yu, Xianjun Yu
PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells. Science advances 10 (4) (2024)
He Xu, Di Wu, Mingming Xiao, Yubin Lei, Yalan Lei, Xian-Jun Yu, Xianjun Yu
PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells. Science advances 10 (4) (2024)
He Xu, Di Wu, Mingming Xiao, Yubin Lei, Yalan Lei, Xian-Jun Yu, Xianjun Yu
PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells. Science advances 10 (4) (2024)
He Xu, Di Wu, Mingming Xiao, Yubin Lei, Yalan Lei, Xian-Jun Yu, Xianjun Yu
PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells. Science advances 10 (4) (2024)
Mingming Xiao, Jing Yang, Mingwei Dong, Xiaoqi Mao, Haoqi Pan, Yalan Lei, Xuhui Tong, Xiaoning Yu, Xianjun Yu, Xianjun Yu
NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy. Cell death & disease 15 (8) (2024)
Mingming Xiao, Jing Yang, Mingwei Dong, Xiaoqi Mao, Haoqi Pan, Yalan Lei, Xuhui Tong, Xiaoning Yu, Xianjun Yu, Xianjun Yu
NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy. Cell death & disease 15 (8) (2024)